Source: Annual Congress 2003 - New developments in lung transplantation
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. L. Arreola, L. M. Montaño, E. Flores, B. Sommer, M. H. Vargas (Mexico City, Mexico). The blockade of substance P receptors avoids the derangement of the vascular permeability during experimental donor-lung preservation. Eur Respir J 2003; 22: Suppl. 45, 2080

Member's Comments

No comment yet.

Related content which might interest you: Optimization of tissue targeting properties of macitentan, a new dual endothelin receptor antagonist, improves its efficacy in a rat model of pulmonary fibrosis associated with pulmonary arterial hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 NMDA receptor activation promotes vascular remodeling and pulmonary arterial hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Echocardiographyc and histomorphometric assessment of the effects of pharmacological antagonism of endothelin receptors in the Sugen 5416/hypoxia rat model of pulmonary hypertension Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 The inflammatory response of pulmonary vascular smooth muscle cells to bacterial endotoxin is sensitive to endothelin receptor antagonism Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Endothelin-1 receptor antagonist prevents hyperoxia-induced parenchymal mechanical impairment in mice Source: Eur Respir J 2004; 24: Suppl. 48, 334s Year: 2004 Dual endothelin-1 receptor antagonism prevents chronic intermittent hypoxia-induced cardiovascular alterations in rats Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing Year: 2008 Role of airway smooth muscles in chronic airway inflammation and lung fibrosis and possible therapeutic potential of endothelin receptor antagonism Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010 The effect of estrogen and its receptor on hypoxic pulmonary vascular remodeling Source: Eur Respir J 2006; 28: Suppl. 50, 658s Year: 2006 PTEN reduces vascular endothelial growth factor–mediated vascular permeability in asthma Source: Eur Respir J 2005; 26: Suppl. 49, 581s Year: 2005 Effects of AT1 receptor blockade on pulmonary and systemic manifestations in a COPD/emphysema mouse model Source: Annual Congress 2009 - Preclinical models in drug development Year: 2009 Effect of prior statin therapy on capillary permeability in the lungs after cardiac or vascular surgery Source: Eur Respir J 2006; 27: 1026-1032 Year: 2006 The evaluation of airways mucosa vascular endothelial dysfunction Source: Eur Respir J 2004; 24: Suppl. 48, 560s Year: 2004 Endothelin-1-induced airway and parenchymal mechanical responses in guinea-pigs: the roles of ETA and ETB receptors Source: Eur Respir J 2001; 17: 975-981 Year: 2001 Role of muscarinic receptors in airway inflammation and remodelling Source: International Congress 2015 – Respiratory research in the Netherlands Year: 2015 In vitro effects of vasodilatory drugs on BMPR2-silenced pulmonary microvascular endothelial cell function Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Iloprost protects against lung endothelial barrier dysfunction and vascular leak via Rap1 Source: Annual Congress 2009 - Crossing the line: alveolo-capillary barrier control in acute lung injury Year: 2009 Loss of Bmp9 does not lead to spontaneous pulmonary hypertension, but attenuates vascular remodeling in experimental models Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Mitochondrial dysfunction in airway epithelium increases pro-inflammatory IL-8, impairs barrier function and reduces glucocorticoid responsiveness Source: Annual Congress 2011 - Lung cell biology Year: 2011 CFTR dysfunction induces vascular endothelial growth factor synthesis in airway epithelium Source: Eur Respir J 2013; 42: 1553-1562 Year: 2013 Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012